© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ONC MRD NXT-GNRJ ALYS 1ST | Medium Descr | ONC MRD NEXT-GNRJ TRGT SEQ ALYS CLL-FR DNA 1ST | Long Descr | Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient-specific panel for future comparisons to evaluate for MRD | CLIA Waived (QW) | No | APC Status Indicator | Service Paid under Fee Schedule or Payment System other than OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2023-01-01 | Added | First appearance in codebook. |
| 2023-01-01 | Changed | Code description changed. |
| 2022-04-01 | Added | Code added. |
Get instant expert-level medical coding assistance.